Difference between revisions of "Part:BBa K1041001:Experience"

(→‎User Reviews)
(→‎Sequencing)
Line 11: Line 11:
  
 
===Sequencing===
 
===Sequencing===
−
The biobrick was sent off to a company for sequencing.
+
The biobrick was sent off to a company for sequencing and the data we received back ''Fig'' showed the DNA is of good quality.  
  
−
[[image:3a vf2 0-540.JPG|thumb|left|K1041000 sequencing data part 1]]
 
−
[[image:3a vf2 440-860.JPG|thumb|left|K1041000 sequencing data part 2 ]]
 
−
[[image:3a vf2 860-.JPG|thumb|left|K1041000 sequencing data part 3]]
 
  
 
<br>
 
<br>
Line 26: Line 23:
 
<br>
 
<br>
 
<br>
 
<br>
 +
 
===BLAST Analysis===
 
===BLAST Analysis===
 
The data we recieved back from the sequencing company was aligned using BLAST with the expected DNA sequence. The sequencing with both the forward and reverse primers had over 98% matches with the expected DNA sequence.   
 
The data we recieved back from the sequencing company was aligned using BLAST with the expected DNA sequence. The sequencing with both the forward and reverse primers had over 98% matches with the expected DNA sequence.   

Revision as of 08:48, 20 September 2013


This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.

Team NRP-UEA_Norwich 2013

Team NRP-UEA_Norwich 2013 designed this part to contain the promoter sequence AntG, where the unique sigma factor AntA binds to activate transcription of the neomycin resistance gene. There is a Nde1 resticition site between the promoter and gene to allow either to be removed and exchanged for a different promoter or gene. This facilitated cloning of the biobrick Bba_K1041002

Characterisation of this biobrick involved sequencing, restriction digests and BLAST analysis.

Sequencing

The biobrick was sent off to a company for sequencing and the data we received back Fig showed the DNA is of good quality.











BLAST Analysis

The data we recieved back from the sequencing company was aligned using BLAST with the expected DNA sequence. The sequencing with both the forward and reverse primers had over 98% matches with the expected DNA sequence.

Fig: Forward primer K1041001 sequencing data aligned with the expected DNA sequence
Fig: Reverse primer K1041001 sequencing data aligned with the expected DNA sequence

User Reviews

UNIQbecc91e1139eec3e-partinfo-00000000-QINU UNIQbecc91e1139eec3e-partinfo-00000001-QINU